Rüsselsheim, Germany

Anke Kaltbeitzel

This inventor holds 7 USPTO granted patents. Top assignee: Hoechst Aktiengesellschaft. Active years: 1994-1998.


% Patents Active = 100.0

Average Co-Inventor Count = 3.8

ph-index = 3

Forward Citations = 39(Granted Patents)


Location History:

  • Ru, DE (1994)
  • Ruesselsheim, DE (1995)
  • Russelsheim, DE (1994 - 1998)

Company Filing History:


Years Active: 1994-1998

Loading Chart...
7 patents (USPTO):Explore Patents

Title: Anke Kaltbeitzel: Innovator in Liquid-Crystal Technology

Introduction

Anke Kaltbeitzel is a prominent inventor based in Rüsselsheim, Germany. She has made significant contributions to the field of liquid-crystal technology, holding a total of 7 patents. Her work has been instrumental in advancing the applications of liquid crystals in various industries.

Latest Patents

Among her latest patents are innovative compounds for use in liquid-crystal mixtures. Notably, she has developed compounds of the formula (I) and chiral oxiranylmethyl ethers, which serve as dopants in liquid-crystal applications. These advancements highlight her expertise and commitment to enhancing liquid-crystal technologies.

Career Highlights

Anke Kaltbeitzel is currently employed at Hoechst Aktiengesellschaft, where she continues to push the boundaries of liquid-crystal research. Her career is marked by a dedication to innovation and a focus on practical applications of her inventions.

Collaborations

Throughout her career, Anke has collaborated with notable colleagues, including Hubert Schlosser and Rainer Wingen. These partnerships have fostered a collaborative environment that encourages the exchange of ideas and expertise.

Conclusion

Anke Kaltbeitzel's contributions to liquid-crystal technology and her impressive portfolio of patents underscore her role as a leading inventor in her field. Her work continues to influence advancements in technology and innovation.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…